Goldman Sachs Group Inc Arvinas, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Arvinas, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 754,126 shares of ARVN stock, worth $19.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
754,126
Previous 594,425 26.87%
Holding current value
$19.4 Million
Previous $15.8 Million 17.39%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$23.66 - $32.73 $3.78 Million - $5.23 Million
159,701 Added 26.87%
754,126 $18.6 Million
Q2 2024

Aug 13, 2024
BUY
$24.46 - $40.4 $538 - $888
22 Added 0.0%
594,425 $15.8 Million
Q1 2024

May 15, 2024
BUY
$36.38 - $52.31 $9.64 Million - $13.9 Million
264,944 Added 80.42%
594,403 $24.5 Million
Q4 2023

Feb 13, 2024
BUY
$14.19 - $42.33 $1.91 Million - $5.71 Million
134,809 Added 69.26%
329,459 $13.6 Million
Q3 2023

May 14, 2024
SELL
$19.64 - $28.21 $2.65 Million - $3.8 Million
-134,809 Reduced 40.92%
194,650 $3.82 Million
Q3 2023

Nov 14, 2023
SELL
$19.64 - $28.21 $1.54 Million - $2.21 Million
-78,230 Reduced 28.67%
194,650 $3.82 Million
Q2 2023

May 14, 2024
SELL
$21.73 - $31.43 $526,648 - $761,737
-24,236 Reduced 8.16%
272,880 $6.77 Million
Q2 2023

Aug 14, 2023
SELL
$21.73 - $31.43 $526,648 - $761,737
-24,236 Reduced 8.16%
272,880 $6.77 Million
Q1 2023

May 14, 2024
SELL
$26.15 - $37.26 $2.2 Million - $3.13 Million
-84,136 Reduced 22.07%
297,116 $8.12 Million
Q1 2023

May 11, 2023
SELL
$26.15 - $37.26 $2.2 Million - $3.13 Million
-84,136 Reduced 22.07%
297,116 $8.12 Million
Q4 2022

May 14, 2024
SELL
$32.47 - $57.24 $6.73 Million - $11.9 Million
-207,276 Reduced 35.22%
381,252 $13 Million
Q4 2022

Feb 13, 2023
SELL
$32.47 - $57.24 $6.73 Million - $11.9 Million
-207,276 Reduced 35.22%
381,252 $13 Million
Q3 2022

May 14, 2024
BUY
$41.87 - $57.99 $8.94 Million - $12.4 Million
213,476 Added 56.92%
588,528 $26.2 Million
Q3 2022

Nov 10, 2022
BUY
$41.87 - $57.99 $8.94 Million - $12.4 Million
213,476 Added 56.92%
588,528 $26.2 Million
Q2 2022

May 14, 2024
BUY
$36.01 - $74.24 $1.64 Million - $3.38 Million
45,593 Added 13.84%
375,052 $15.8 Million
Q2 2022

Aug 15, 2022
BUY
$36.01 - $74.24 $4.1 Million - $8.46 Million
113,907 Added 43.62%
375,052 $15.8 Million
Q1 2022

May 16, 2022
SELL
$60.27 - $81.57 $1.15 Million - $1.55 Million
-19,045 Reduced 6.8%
261,145 $17.6 Million
Q4 2021

Feb 14, 2022
SELL
$65.85 - $96.21 $6.06 Million - $8.85 Million
-92,007 Reduced 24.72%
280,190 $23 Million
Q3 2021

Nov 10, 2021
BUY
$73.2 - $107.87 $27.2 Million - $40.1 Million
372,197 New
372,197 $30.6 Million

Others Institutions Holding ARVN

# of Institutions
229
Shares Held
68.4M
Call Options Held
226K
Put Options Held
285K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.37B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email